Neurodevelopmental Disorders
Sage Therapeutics Rejects Biogen’s Acquisition Proposal, Remains Open to Future Deals
Sage Therapeutics, Biogen, Acquisition Proposal, Postpartum Depression, ZURZUVAE, Neurodevelopmental Disorders, Neuropsychiatry
Actionable Insights Powered by AI
Sage Therapeutics, Biogen, Acquisition Proposal, Postpartum Depression, ZURZUVAE, Neurodevelopmental Disorders, Neuropsychiatry